Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.
Gutiérrez-Díaz I, Sanz-Martinez M, Castro AM, Rodríguez-Belvís MV, Carreira N, Jiménez S, Mangas C, Queralt M, Herrador M, Martín-Masot R, Ferrer P, Navas-López VM, Espín B, Leis R, Díaz JJ, Delgado S. Gutiérrez-Díaz I, et al. Among authors: rodriguez belvis mv. Eur J Pediatr. 2023 Oct;182(10):4633-4645. doi: 10.1007/s00431-023-05140-8. Epub 2023 Aug 9. Eur J Pediatr. 2023. PMID: 37555973 Free PMC article.
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.
Garcia-Romero R, de Zabarte Fernandez JMM, Pujol-Muncunill G, Donat-Aliaga E, Segarra-Cantón O, Irastorza-Terradillos I, Medina-Benitez E, Ruiz-Hernández CJ, Carrillo-Palau M, Ros-Arnal I, Rodriguez-Martínez A, Escartin-Madurga L, Gutiérrez-Junquera C, Vicente-Santamaría S, Rodriguez-Belvis MV, Fernández-Fernández S, Alberto-Alonso JR, Montraveta M, Torres-Peral R, Navalon-Rubio M, Navas-López VM, de Carpi JM. Garcia-Romero R, et al. Among authors: rodriguez belvis mv. Eur J Pediatr. 2021 Sep;180(9):3039-3040. doi: 10.1007/s00431-021-04117-9. Eur J Pediatr. 2021. PMID: 34027626 Free article. No abstract available.
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
Yerushalmy-Feler A, Pujol-Muncunill G, Martin-de-Carpi J, Kolho KL, Levine A, Olbjørn C, Granot M, Bramuzzo M, Rolandsdotter H, Mouratidou N, Hradsky O, Scarallo L, Matar M, Rimon RM, Rinawi F, Shalem T, Najajra H, de Meij T, Aloi M, Rodríguez-Belvís MV, Alvisi P, Schneider AM, van Rheenen P, Navas-López VM, Kiparissi F, Barrio J, Turner D, Cohen S. Yerushalmy-Feler A, et al. Among authors: rodriguez belvis mv. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):717-723. doi: 10.1097/MPG.0000000000003608. Epub 2022 Sep 8. J Pediatr Gastroenterol Nutr. 2022. PMID: 36084231
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
Cohen S, Rolandsdotter H, Kolho KL, Turner D, Tzivinikos C, Bramuzzo M, Pujol-Muncunill G, Scarallo L, Urlep D, Rinawi F, Granot M, Kang B, Longueville Y, Rodríguez-Belvís MV, Weintraub Y, Navas-López VM, Yerushalmy-Feler A. Cohen S, et al. Among authors: rodriguez belvis mv. Paediatr Drugs. 2024 May 23. doi: 10.1007/s40272-024-00631-z. Online ahead of print. Paediatr Drugs. 2024. PMID: 38780740